Teva’s New York Opioid Liability Climbs To $523m With Settlement Deal
President And CEO Kåre Schultz: ‘We Are Quite Satisfied With Outcome’
Teva is on the hook to pay more than $300m to New York state over the next 18 years, in addition to $210m in damages already agreed under its proposed nationwide settlement deal, after settling claims with the New York Attorney General.
